The latest weight-loss wonder drugs might come with an unexpected side effect: scurvy. Yes, scurvy — the disease historically associated with pirates and sailors — has emerged as a potential risk for users of popular GLP-1 medications like Ozempic and Wegovy, according to Australian researchers who warn that dramatic appetite suppression could lead to dangerous nutritional deficiencies.
The Price of Quick Weight Loss
Researchers from the Hunter Medical Research Institute in Australia have raised alarms about the potential for malnutrition among users of GLP-1 medications, which can reduce calorie intake by a staggering 16-39%. While these drugs have been celebrated for producing significant weight loss — between 7.9% and 17.3% of body weight — their impact on nutritional health remains poorly understood.
“A reduction in body weight does not automatically mean the person is well-nourished or healthy,” the researchers cautioned in their findings, highlighting a critical gap in how these medications are evaluated.
What’s particularly concerning? Clinical trials for these medications have largely failed to report actual food intake patterns, leaving patients and healthcare providers in the dark about potential nutritional risks. Up to 40% of the weight lost while using these drugs can be lean body mass, including valuable muscle tissue, according to recent studies.
Battling Through Side Effects
Despite uncomfortable — and sometimes severe — side effects, many users continue treatment, prioritizing the weight loss benefits over physical discomfort. Around 80% of Ozempic users report non-weight-related symptoms, with gastrointestinal complaints topping the list. Approximately 62% experience issues like nausea, vomiting, and constipation, yet most continue their treatment regimen.
Diarrhea affects roughly 9% of those using Ozempic for Type 2 diabetes, but that number jumps to a whopping 30% for those taking it specifically for weight loss — likely due to the higher doses prescribed for weight management. Women appear more likely to report both GI side effects and headaches than men.
The digestive distress isn’t just uncomfortable — it can be dangerous. Beyond the common side effects of nausea, vomiting, diarrhea, and constipation, these medications carry risks of more serious complications, including gallbladder problems and kidney damage from dehydration.
Beyond Discomfort: Serious Risks
In rare but alarming cases, Ozempic has been linked to gastroparesis (stomach paralysis) and intestinal blockage, known as ileus. The FDA has documented cases of these severe complications, including two deaths associated with intestinal blockage.
And then there’s what some call “Ozempic face” — the cosmetic effect of rapid weight loss that can leave users with a gaunt, aged appearance. While not medically dangerous, this side effect has become a common complaint among those using GLP-1 medications.
The Nutritional Blind Spot
Perhaps the most overlooked aspect of these medications is their impact on overall nutrition. When appetite plummets, so does the intake of essential vitamins and minerals. The manufacturer’s own website acknowledges the digestive side effects but offers little guidance on maintaining proper nutrition while taking the drug.
Is it possible to lose weight too effectively? That appears to be the paradox at the heart of the GLP-1 revolution. These medications work precisely because they dramatically reduce food intake — but that same mechanism creates vulnerability to nutritional deficiencies like scurvy, caused by insufficient vitamin C.
For patients and healthcare providers alike, these findings highlight the need for nutritional monitoring alongside weight measurements. As millions more turn to these medications for weight management, the medical community faces a pressing challenge: ensuring that the cure for obesity doesn’t create new health problems along the way.
